NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/07/2025
Back to search
Official data from USPTO
GENFIT TOWARDS BETTER MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
60
Latest update
11/08/2025
Trademark type
Combined
Nice classes
5
Filing date
05/09/2016
Registration date
07/23/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/07/2025
Last transaction
11/08/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
99
Owner location
Loos, FR
Examiner
BELENKER, ESTHER
Current location
Historical data usage
Mark description
The mark consists of of the word "GENFIT" in blue, the words "TOWARDS BETTER MEDICINE" in orange; and a sphere in orange and blue and slanted lines on the sphere in white.
Holders and representatives
Holders
GENFIT
Representatives
Ronald M. Kachmarik Cooper Legal Group LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalveterinary preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculoskeletal systemthe genitourinary system; pharmaceutical and veterinary preparations for the treatment of inflammatory disorders; pharmaceutical and veterinary preparations for use in dermatologyin the prevention and treatment of cancersin the treatment of infectious diseases of the blood and in tissue and organ transplantationin the treatment of eye diseases and conditions and for gastroenterological disorders; pharmaceutical preparations for skin care; pharmaceutical preparations for preventing and treating sunburn; slimming medical preparations; cultures of microorganism for medical or veterinary use; culture media for cultivating microorganism; nutritive substances for microorganisms for medical purposescells for medicalclinical or veterinary use; pharmaceutical and veterinary compounds for human or animal use to treat metabolic disorderscardiovascular diseasesdermatological diseasesdisorders in the central nervous systemcancersasthmaallergieslipid disordersobesity and diabetes; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical or veterinary use; sanitary preparations for medical use; dietetic foodstuffs for medical use; and food supplements for medical use
Publications
History of USPTO decisions and trademark events.
60 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/07/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/07/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/22/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/22/2025
E815
TEAS SECTION 8 & 15 RECEIVED
07/17/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/23/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2019
PUBO
PUBLISHED FOR OPPOSITION
05/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/17/2019
RPUB
NOA CANCELLED; REPUBLICATION REQUIRED
04/02/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/02/2019
PBIU
WITHDRAWN FROM PUB-ITU REQUEST
04/01/2019
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
03/26/2019
APET
ASSIGNED TO PETITION STAFF
03/25/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/19/2019
IUCN
NOTICE OF ALLOWANCE CANCELLED
03/13/2019
EX3G
SOU EXTENSION 3 GRANTED
03/13/2019
EXT3
SOU EXTENSION 3 FILED
03/13/2019
EEXT
SOU TEAS EXTENSION RECEIVED
03/13/2019
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
03/13/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/28/2018
EX2G
SOU EXTENSION 2 GRANTED
09/26/2018
EXT2
SOU EXTENSION 2 FILED
09/26/2018
EEXT
SOU TEAS EXTENSION RECEIVED
09/26/2018
DOCK
ASSIGNED TO EXAMINER
08/10/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/28/2018
EX1G
SOU EXTENSION 1 GRANTED
03/26/2018
EXT1
SOU EXTENSION 1 FILED
03/26/2018
EEXT
SOU TEAS EXTENSION RECEIVED
03/26/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/26/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/01/2017
PUBO
PUBLISHED FOR OPPOSITION
08/01/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/12/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/29/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/22/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
06/21/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/21/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
06/21/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/21/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/20/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
06/20/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/20/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/06/2017
GNRT
NON-FINAL ACTION E-MAILED
03/06/2017
CNRT
NON-FINAL ACTION WRITTEN
03/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/02/2017
ALIE
ASSIGNED TO LIE
02/26/2017
ALIE
ASSIGNED TO LIE
02/12/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/30/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/24/2016
GNRT
NON-FINAL ACTION E-MAILED
08/24/2016
CNRT
NON-FINAL ACTION WRITTEN
08/24/2016
DOCK
ASSIGNED TO EXAMINER
08/24/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/13/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/12/2016
NWAP
NEW APPLICATION ENTERED
05/12/2016
Continuous trademark protection
Get notified about every new filing that threatens GENFIT TOWARDS BETTER MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.